|
|
|
|
Viralytics Broadens IP Portfolio
SYDNEY, Australia, Nov.6, 2008: Viralytics Limited (ASX: VLA) has received a Notice of Allowance from the United States Patent Office for its patent application covering the use of Echoviruses (including EVATAKTM) for the treatment of all...
|
|
|
Viralytics secures EU patent
Australia based Viralytics has been granted a European patent covering the companys core technology.The granted European patent provides Viralytics with exclusive use of Coxsackie A group viruses (including the companys lead product...
|
|
|
Viralytics secures key EU patent
iralytics Limited announced that the company has been granted a European patent covering the companys core technology.The Company had announced in May 2008 that a 'Notice of Allowance had been received and that subject to the completion...
|
|
|
Viralytics Secures Key EU Patent
-Viralytics Limited (ASX: VLA) announced today that the company has been granted a European patent covering the company's core technology.The Company had announced in May 2008 that a 'Notice of Allowance' had been received and that...
|
|
|
Viralytics secures key EU patent
Singapore, oct 24, 2008: Viralytics has been granted a European patent covering the companys core technology.Early in May this year, Viralytics had announced that a Notice of Allowance had been received and that subject to the completion...
|
